{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 5151, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "Includes Taro and Citi logos.", "imagePath": "https://imgproxy.kitesheet.com/KNQQF9Y_UFaNffr_Z6HlmOuhuhNZmykXRzchtJtl-3E/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9qYXJ2aXMtMTAtaWJkLXByZXNlbnRhdGlvbi0yMDEyLXRhcm8tcGhhcm1hY2V1dGljYWwtaW5kdXN0cmllcy1jaXRpZ3JvdXAvcDAwMS5qcGc", "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/1", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "efccf951-8a44-4762-b8dd-dffbd7e71970", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents a company overview and recent financial performance", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/ryrjdVtzOMKTrW_2lZsOQdM2D85JuNVD5Y8Qr5NcuSU/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9qYXJ2aXMtMTAtaWJkLXByZXNlbnRhdGlvbi0yMDEyLXRhcm8tcGhhcm1hY2V1dGljYWwtaW5kdXN0cmllcy1jaXRpZ3JvdXAvcDAwMS5wbmc", "thumbSrc": "https://imgproxy.kitesheet.com/xywObPU1tgSsMT0lV212NeqB2ApXaF2ul6GjMTlrIJM/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9qYXJ2aXMtMTAtaWJkLXByZXNlbnRhdGlvbi0yMDEyLXRhcm8tcGhhcm1hY2V1dGljYWwtaW5kdXN0cmllcy1jaXRpZ3JvdXAvcDAwMS5qcGc", "thumbSrcAlt": "https://imgproxy.kitesheet.com/HgVNnO2mCt5TFxq1GlsHS5FyysMY8qOtGxrtPdtJle0/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9qYXJ2aXMtMTAtaWJkLXByZXNlbnRhdGlvbi0yMDEyLXRhcm8tcGhhcm1hY2V1dGljYWwtaW5kdXN0cmllcy1jaXRpZ3JvdXAvcDAwMS5wbmc" }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/2", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "efccf951-8a44-4762-b8dd-dffbd7e71970", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents a company overview and recent financial performance", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 3, "slideType": "table_of_contents", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/3", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "efccf951-8a44-4762-b8dd-dffbd7e71970", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents a company overview and recent financial performance", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 4, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/4", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "efccf951-8a44-4762-b8dd-dffbd7e71970", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents a company overview and recent financial performance", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 5, "slideType": "executive_summary", "function": "establish_context", "notes": "Includes a financial snapshot with valuation multiples and a product-level sales table.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/5", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "efccf951-8a44-4762-b8dd-dffbd7e71970", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents a company overview and recent financial performance", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 6, "slideType": "other", "function": "analyze_data", "notes": "The chart uses a dual-axis approach to show price (line) and volume (bars) with annotated callouts for specific events.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/6", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 6, "beatId": "bf50e422-96a9-446c-90f1-ef787140617a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The document provides context for Taro's financial performance", "position": 1, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 7, "slideType": "other", "function": "analyze_data", "notes": "The slide highlights the lack of analyst coverage and low float (34%) resulting in low trading volume for Taro Pharma.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/7", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 6, "beatId": "bf50e422-96a9-446c-90f1-ef787140617a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The document provides context for Taro's financial performance", "position": 1, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 8, "slideType": "executive_summary", "function": "analyze_data", "notes": "The slide uses a mix of historical (A) and estimated (E) data, with specific H1 comparisons.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/8", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 6, "beatId": "bf50e422-96a9-446c-90f1-ef787140617a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The document provides context for Taro's financial performance", "position": 1, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" }, { "to": 14, "from": 8, "beatId": "3645375d-f4dc-48bf-b0fa-4457c0ee9f91", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The document presents detailed financial data and peer benchmarking", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 9, "slideType": "other", "function": "analyze_data", "notes": "The slide uses a combination of annual historical/forecast data and half-year comparisons to explain cost structure changes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/9", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "3645375d-f4dc-48bf-b0fa-4457c0ee9f91", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The document presents detailed financial data and peer benchmarking", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 10, "slideType": "executive_summary", "function": "analyze_data", "notes": "Includes a detailed income statement table with Q1, Q2, H1 2012 actuals and 2012 estimates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/10", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "3645375d-f4dc-48bf-b0fa-4457c0ee9f91", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The document presents detailed financial data and peer benchmarking", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 11, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/11", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "3645375d-f4dc-48bf-b0fa-4457c0ee9f91", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The document presents detailed financial data and peer benchmarking", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 12, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "Includes two bar charts showing historical/projected growth and a median benchmark line.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/12", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-12", "loopMatches": [ { "to": 14, "from": 12, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "f7b706e2-cbe9-4c86-a2b1-72d90dd7a7df", "evidence": "The document presents multiple peer benchmarking analyses", "position": 0, "objective": "Identify patterns in peer benchmarking", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "3645375d-f4dc-48bf-b0fa-4457c0ee9f91", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The document presents detailed financial data and peer benchmarking", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 13, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "Taro is highlighted in blue in each chart, while peers are in grey. Medians are indicated by red dashed lines.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/13", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-13", "loopMatches": [ { "to": 14, "from": 12, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "f7b706e2-cbe9-4c86-a2b1-72d90dd7a7df", "evidence": "The document presents multiple peer benchmarking analyses", "position": 0, "objective": "Identify patterns in peer benchmarking", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "3645375d-f4dc-48bf-b0fa-4457c0ee9f91", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The document presents detailed financial data and peer benchmarking", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 14, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "Includes specific footnotes regarding adjustments for peer data (e.g., Actavis, Paddock, Flomax).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/14", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-14", "loopMatches": [ { "to": 14, "from": 12, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "f7b706e2-cbe9-4c86-a2b1-72d90dd7a7df", "evidence": "The document presents multiple peer benchmarking analyses", "position": 0, "objective": "Identify patterns in peer benchmarking", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "3645375d-f4dc-48bf-b0fa-4457c0ee9f91", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The document presents detailed financial data and peer benchmarking", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 15, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/15", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-15", "loopMatches": [ { "to": 20, "from": 15, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "69a62026-f22f-4cb8-8315-67f1e16e19c1", "evidence": "The document presents various valuation metrics and analyses", "position": 1, "objective": "Understand the valuation of Taro", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "39dffcbe-e19a-4cdd-9f0a-ea53bf4e24c8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Valuation", "beatSlug": null, "evidence": "The document presents various valuation metrics and analyses", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 16, "slideType": "comparison_table", "function": "compare_peers", "notes": "Includes specific financial benchmarks like P/E ratios and valuation ranges relative to Sun Pharma's offer price.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/16", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-16", "loopMatches": [ { "to": 20, "from": 15, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "69a62026-f22f-4cb8-8315-67f1e16e19c1", "evidence": "The document presents various valuation metrics and analyses", "position": 1, "objective": "Understand the valuation of Taro", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "39dffcbe-e19a-4cdd-9f0a-ea53bf4e24c8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Valuation", "beatSlug": null, "evidence": "The document presents various valuation metrics and analyses", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 17, "slideType": "comparison_table", "function": "cite_precedent", "notes": "Includes data on price bumps, offer premiums, and transaction duration.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/17", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-17", "loopMatches": [ { "to": 20, "from": 15, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "69a62026-f22f-4cb8-8315-67f1e16e19c1", "evidence": "The document presents various valuation metrics and analyses", "position": 1, "objective": "Understand the valuation of Taro", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "39dffcbe-e19a-4cdd-9f0a-ea53bf4e24c8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Valuation", "beatSlug": null, "evidence": "The document presents various valuation metrics and analyses", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 18, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes sensitivity tables for WACC vs Terminal EBITDA Multiple, WACC vs Implied Perpetuity Growth Rate, and WACC vs Terminal Value as a % of Enterprise Value.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/18", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-18", "loopMatches": [ { "to": 20, "from": 15, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "69a62026-f22f-4cb8-8315-67f1e16e19c1", "evidence": "The document presents various valuation metrics and analyses", "position": 1, "objective": "Understand the valuation of Taro", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "39dffcbe-e19a-4cdd-9f0a-ea53bf4e24c8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Valuation", "beatSlug": null, "evidence": "The document presents various valuation metrics and analyses", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 19, "slideType": "appendix_data", "function": "analyze_data", "notes": "The chart highlights a period of multiple uplift attributed to stock price appreciation ahead of product pricing increases.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/19", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-19", "loopMatches": [ { "to": 20, "from": 15, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "69a62026-f22f-4cb8-8315-67f1e16e19c1", "evidence": "The document presents various valuation metrics and analyses", "position": 1, "objective": "Understand the valuation of Taro", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "39dffcbe-e19a-4cdd-9f0a-ea53bf4e24c8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Valuation", "beatSlug": null, "evidence": "The document presents various valuation metrics and analyses", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 20, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "Includes median lines for the full peer set and a sub-segment of sub-$5bn market cap peers.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/20", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-20", "loopMatches": [ { "to": 20, "from": 15, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "69a62026-f22f-4cb8-8315-67f1e16e19c1", "evidence": "The document presents various valuation metrics and analyses", "position": 1, "objective": "Understand the valuation of Taro", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "39dffcbe-e19a-4cdd-9f0a-ea53bf4e24c8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Valuation", "beatSlug": null, "evidence": "The document presents various valuation metrics and analyses", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 21, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/21", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 22, "slideType": "appendix_data", "function": "analyze_data", "notes": "Depreciation and amortization allocated 75%:25% between COGS and SG&A per Taro management.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/22", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-22", "loopMatches": [ { "to": 25, "from": 22, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f1229c70-3fe1-42a6-bbed-1b8b803de368", "evidence": "The document presents forecasted financial data and valuation analyses", "position": 2, "objective": "Highlight the importance of taking action", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.5, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 23, "slideType": "comparison_table", "function": "compare_peers", "notes": "Includes mean and median calculations for the peer group and a sub-segment of peers under $5bn market cap.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/23", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-23", "loopMatches": [ { "to": 25, "from": 22, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f1229c70-3fe1-42a6-bbed-1b8b803de368", "evidence": "The document presents forecasted financial data and valuation analyses", "position": 2, "objective": "Highlight the importance of taking action", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.5, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 24, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes a legend for healthcare deals and footnotes regarding data sources and methodology.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/24", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-24", "loopMatches": [ { "to": 25, "from": 22, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f1229c70-3fe1-42a6-bbed-1b8b803de368", "evidence": "The document presents forecasted financial data and valuation analyses", "position": 2, "objective": "Highlight the importance of taking action", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.5, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 25, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes a legend for healthcare deals and a note about exclusions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/25", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-25", "loopMatches": [ { "to": 25, "from": 22, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f1229c70-3fe1-42a6-bbed-1b8b803de368", "evidence": "The document presents forecasted financial data and valuation analyses", "position": 2, "objective": "Highlight the importance of taking action", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.5, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 26, "slideType": "appendix_data", "function": "analyze_data", "notes": "Market data as of August 10, 2012. Cost of debt estimated based on current B rated high yield index.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/26", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d87d-74a8-98e5-6fc840cf4742", "docSlug": "jarvis-10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "documentTitle": "10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup", "authorId": "10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2012-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 27, "slideType": "appendix_disclosure", "function": "other", "notes": "The slide combines a dense legal disclaimer block with a paragraph describing corporate sustainability efforts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d87d-74a8-98e5-6fc840cf4742/27", "deckHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742", "deckAnchorHref": "/decks/019f6b8e-d87d-74a8-98e5-6fc840cf4742#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d8e9-74af-9146-eb1385543bcd", "docSlug": "jarvis-11-laws-of-showrunning-mean-version", "documentTitle": "11 laws of showrunning mean version", "authorId": "11-laws-of-showrunning-mean-version", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": null, "orientation": null, "aspectRatio": null, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "This appears to be the first page of a 48-page document/essay.", "imagePath": "https://imgproxy.kitesheet.com/0-DDtvwdNokLLJlYKAWvXlYWB3R8sM3vpSK8uvNR0ps/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9qYXJ2aXMtMTEtbGF3cy1vZi1zaG93cnVubmluZy1tZWFuLXZlcnNpb24vcDAwMS5qcGc", "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d8e9-74af-9146-eb1385543bcd/1", "deckHref": "/decks/019f6b8e-d8e9-74af-9146-eb1385543bcd", "deckAnchorHref": "/decks/019f6b8e-d8e9-74af-9146-eb1385543bcd#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "1ee445be-2acf-48b9-93cd-6cc982beea01", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The cover slide and introduction grab attention.", "position": 0, "confidence": 0.7, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/kvThCup2P_aLs_iOvVxqGMQiOpOkMze5MV3z0njrnco/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9qYXJ2aXMtMTEtbGF3cy1vZi1zaG93cnVubmluZy1tZWFuLXZlcnNpb24vcDAwMS5wbmc", "thumbSrc": "https://imgproxy.kitesheet.com/iADG7R1wQ43dCPpRR2fcfdYDoCrNXPXyZaf-KRyQxCk/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9qYXJ2aXMtMTEtbGF3cy1vZi1zaG93cnVubmluZy1tZWFuLXZlcnNpb24vcDAwMS5qcGc", "thumbSrcAlt": "https://imgproxy.kitesheet.com/j8GsNwEu8nTBc3OJxx12blekf5wC2mXMtowpmuSzd_A/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9qYXJ2aXMtMTEtbGF3cy1vZi1zaG93cnVubmluZy1tZWFuLXZlcnNpb24vcDAwMS5wbmc" }, { "docId": "019f6b8e-d8e9-74af-9146-eb1385543bcd", "docSlug": "jarvis-11-laws-of-showrunning-mean-version", "documentTitle": "11 laws of showrunning mean version", "authorId": "11-laws-of-showrunning-mean-version", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": null, "orientation": null, "aspectRatio": null, "pageNumber": 2, "slideType": "other", "function": "establish_context", "notes": "This appears to be a page from a manuscript or long-form document rather than a traditional slide deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d8e9-74af-9146-eb1385543bcd/2", "deckHref": "/decks/019f6b8e-d8e9-74af-9146-eb1385543bcd", "deckAnchorHref": "/decks/019f6b8e-d8e9-74af-9146-eb1385543bcd#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "1ee445be-2acf-48b9-93cd-6cc982beea01", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The cover slide and introduction grab attention.", "position": 0, "confidence": 0.7, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d8e9-74af-9146-eb1385543bcd", "docSlug": "jarvis-11-laws-of-showrunning-mean-version", "documentTitle": "11 laws of showrunning mean version", "authorId": "11-laws-of-showrunning-mean-version", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": null, "orientation": null, "aspectRatio": null, "pageNumber": 3, "slideType": "other", "function": "establish_context", "notes": "The slide is a text-heavy narrative page discussing the economics of TV production and the role of showrunners.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d8e9-74af-9146-eb1385543bcd/3", "deckHref": "/decks/019f6b8e-d8e9-74af-9146-eb1385543bcd", "deckAnchorHref": "/decks/019f6b8e-d8e9-74af-9146-eb1385543bcd#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "1ee445be-2acf-48b9-93cd-6cc982beea01", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The cover slide and introduction grab attention.", "position": 0, "confidence": 0.7, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d8e9-74af-9146-eb1385543bcd", "docSlug": "jarvis-11-laws-of-showrunning-mean-version", "documentTitle": "11 laws of showrunning mean version", "authorId": "11-laws-of-showrunning-mean-version", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": null, "orientation": null, "aspectRatio": null, "pageNumber": 4, "slideType": "other", "function": "frame_problem", "notes": "This appears to be a page from a long-form document or essay rather than a traditional presentation slide.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d8e9-74af-9146-eb1385543bcd/4", "deckHref": "/decks/019f6b8e-d8e9-74af-9146-eb1385543bcd", "deckAnchorHref": "/decks/019f6b8e-d8e9-74af-9146-eb1385543bcd#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "1ee445be-2acf-48b9-93cd-6cc982beea01", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The cover slide and introduction grab attention.", "position": 0, "confidence": 0.7, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d8e9-74af-9146-eb1385543bcd", "docSlug": "jarvis-11-laws-of-showrunning-mean-version", "documentTitle": "11 laws of showrunning mean version", "authorId": "11-laws-of-showrunning-mean-version", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": null, "orientation": null, "aspectRatio": null, "pageNumber": 5, "slideType": "other", "function": "establish_context", "notes": "The text uses an extended metaphor comparing TV production to a retail supply chain.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d8e9-74af-9146-eb1385543bcd/5", "deckHref": "/decks/019f6b8e-d8e9-74af-9146-eb1385543bcd", "deckAnchorHref": "/decks/019f6b8e-d8e9-74af-9146-eb1385543bcd#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "1ee445be-2acf-48b9-93cd-6cc982beea01", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The cover slide and introduction grab attention.", "position": 0, "confidence": 0.7, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d8e9-74af-9146-eb1385543bcd", "docSlug": "jarvis-11-laws-of-showrunning-mean-version", "documentTitle": "11 laws of showrunning mean version", "authorId": "11-laws-of-showrunning-mean-version", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": null, "orientation": null, "aspectRatio": null, "pageNumber": 6, "slideType": "transition", "function": "transition", "notes": "This appears to be a page from a book or a long-form manifesto rather than a traditional slide deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d8e9-74af-9146-eb1385543bcd/6", "deckHref": "/decks/019f6b8e-d8e9-74af-9146-eb1385543bcd", "deckAnchorHref": "/decks/019f6b8e-d8e9-74af-9146-eb1385543bcd#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "6672bd60-e2be-48f8-a01a-5509ecdf1109", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The first law of showrunning establishes a need for clear communication.", "position": 1, "confidence": 0.7, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d8e9-74af-9146-eb1385543bcd", "docSlug": "jarvis-11-laws-of-showrunning-mean-version", "documentTitle": "11 laws of showrunning mean version", "authorId": "11-laws-of-showrunning-mean-version", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": null, "orientation": null, "aspectRatio": null, "pageNumber": 7, "slideType": "key_messages", "function": "summarize", "notes": "The slide is a text-heavy page from a larger document, likely a guide or manifesto on showrunning.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d8e9-74af-9146-eb1385543bcd/7", "deckHref": "/decks/019f6b8e-d8e9-74af-9146-eb1385543bcd", "deckAnchorHref": "/decks/019f6b8e-d8e9-74af-9146-eb1385543bcd#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "6672bd60-e2be-48f8-a01a-5509ecdf1109", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The first law of showrunning establishes a need for clear communication.", "position": 1, "confidence": 0.7, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d8e9-74af-9146-eb1385543bcd", "docSlug": "jarvis-11-laws-of-showrunning-mean-version", "documentTitle": "11 laws of showrunning mean version", "authorId": "11-laws-of-showrunning-mean-version", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": null, "orientation": null, "aspectRatio": null, "pageNumber": 8, "slideType": "other", "function": "establish_context", "notes": "This appears to be a page from a manuscript or a text-heavy educational deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d8e9-74af-9146-eb1385543bcd/8", "deckHref": "/decks/019f6b8e-d8e9-74af-9146-eb1385543bcd", "deckAnchorHref": "/decks/019f6b8e-d8e9-74af-9146-eb1385543bcd#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "6672bd60-e2be-48f8-a01a-5509ecdf1109", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The first law of showrunning establishes a need for clear communication.", "position": 1, "confidence": 0.7, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d8e9-74af-9146-eb1385543bcd", "docSlug": "jarvis-11-laws-of-showrunning-mean-version", "documentTitle": "11 laws of showrunning mean version", "authorId": "11-laws-of-showrunning-mean-version", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": null, "orientation": null, "aspectRatio": null, "pageNumber": 9, "slideType": "key_messages", "function": "summarize", "notes": "The slide is a polemic against lazy management in television production.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d8e9-74af-9146-eb1385543bcd/9", "deckHref": "/decks/019f6b8e-d8e9-74af-9146-eb1385543bcd", "deckAnchorHref": "/decks/019f6b8e-d8e9-74af-9146-eb1385543bcd#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "6672bd60-e2be-48f8-a01a-5509ecdf1109", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The first law of showrunning establishes a need for clear communication.", "position": 1, "confidence": 0.7, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d8e9-74af-9146-eb1385543bcd", "docSlug": "jarvis-11-laws-of-showrunning-mean-version", "documentTitle": "11 laws of showrunning mean version", "authorId": "11-laws-of-showrunning-mean-version", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": null, "orientation": null, "aspectRatio": null, "pageNumber": 10, "slideType": "key_messages", "function": "summarize", "notes": "The text discusses the importance of leadership communication and the distinction between superficial perks and genuine employee loyalty.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d8e9-74af-9146-eb1385543bcd/10", "deckHref": "/decks/019f6b8e-d8e9-74af-9146-eb1385543bcd", "deckAnchorHref": "/decks/019f6b8e-d8e9-74af-9146-eb1385543bcd#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 6, "beatId": "6672bd60-e2be-48f8-a01a-5509ecdf1109", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The first law of showrunning establishes a need for clear communication.", "position": 1, "confidence": 0.7, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 22, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes statutory book value, existing business value, and 10-year new business projections.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/22", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 23, "from": 9, "beatId": "4b29cc36-1092-4c4c-8ea5-84ce8a1ba26d", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Valuation analysis and supporting data", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 23, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a waterfall-style bridge calculation to adjust actuarial value for various business segments and holding company assets/liabilities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/23", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 23, "from": 9, "beatId": "4b29cc36-1092-4c4c-8ea5-84ce8a1ba26d", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Valuation analysis and supporting data", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 24, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/24", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 24, "beatId": "f6e479b9-e78e-4466-b555-8014d6cf5351", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and appendices", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 25, "slideType": "appendix_data", "function": "cite_precedent", "notes": "Includes a summary of median and average metrics at the bottom of the table.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/25", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 24, "beatId": "f6e479b9-e78e-4466-b555-8014d6cf5351", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and appendices", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 26, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/26", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 24, "beatId": "f6e479b9-e78e-4466-b555-8014d6cf5351", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and appendices", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 27, "slideType": "appendix_data", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/27", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 24, "beatId": "f6e479b9-e78e-4466-b555-8014d6cf5351", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and appendices", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 28, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "Includes historical valuation charts for Price / Book Value ex. AOCI and Price / NTM Earnings.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/28", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 24, "beatId": "f6e479b9-e78e-4466-b555-8014d6cf5351", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and appendices", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 29, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes detailed WACC build-up components (Cost of Equity, Cost of Debt) and peer market data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/29", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-29", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 24, "beatId": "f6e479b9-e78e-4466-b555-8014d6cf5351", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and appendices", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 30, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/30", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-30", "loopMatches": [ { "to": 34, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f4bf25f1-62dd-462d-9ffe-5088f1856a88", "evidence": "Discussion of FBL's operating environment and plan", "position": 1, "objective": "To explain the operating environment and plan", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 44, "from": 24, "beatId": "f6e479b9-e78e-4466-b555-8014d6cf5351", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and appendices", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 31, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The slide uses a vertical line to indicate the peer median for each metric.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/31", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-31", "loopMatches": [ { "to": 34, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f4bf25f1-62dd-462d-9ffe-5088f1856a88", "evidence": "Discussion of FBL's operating environment and plan", "position": 1, "objective": "To explain the operating environment and plan", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 44, "from": 24, "beatId": "f6e479b9-e78e-4466-b555-8014d6cf5351", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and appendices", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 32, "slideType": "other", "function": "analyze_data", "notes": "Includes three distinct charts: a combo bar/line chart for spread income, a line chart for yield curves, and a bar chart for yield projections.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/32", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-32", "loopMatches": [ { "to": 34, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f4bf25f1-62dd-462d-9ffe-5088f1856a88", "evidence": "Discussion of FBL's operating environment and plan", "position": 1, "objective": "To explain the operating environment and plan", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 44, "from": 24, "beatId": "f6e479b9-e78e-4466-b555-8014d6cf5351", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and appendices", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 33, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/33", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-33", "loopMatches": [ { "to": 34, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f4bf25f1-62dd-462d-9ffe-5088f1856a88", "evidence": "Discussion of FBL's operating environment and plan", "position": 1, "objective": "To explain the operating environment and plan", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 44, "from": 24, "beatId": "f6e479b9-e78e-4466-b555-8014d6cf5351", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and appendices", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 34, "slideType": "executive_summary", "function": "analyze_data", "notes": "Includes specific disclaimers regarding the 2020E figures and the exclusion of transaction impacts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/34", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-34", "loopMatches": [ { "to": 34, "from": 30, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f4bf25f1-62dd-462d-9ffe-5088f1856a88", "evidence": "Discussion of FBL's operating environment and plan", "position": 1, "objective": "To explain the operating environment and plan", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 44, "from": 24, "beatId": "f6e479b9-e78e-4466-b555-8014d6cf5351", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and appendices", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 35, "slideType": "appendix_data", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/35", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-35", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 24, "beatId": "f6e479b9-e78e-4466-b555-8014d6cf5351", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and appendices", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 36, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The slide uses a table structure to compare two brokers side-by-side, incorporating bar charts for trend visualization.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/36", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-36", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 24, "beatId": "f6e479b9-e78e-4466-b555-8014d6cf5351", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and appendices", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 37, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/37", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-37", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 24, "beatId": "f6e479b9-e78e-4466-b555-8014d6cf5351", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and appendices", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 38, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table breaks down basic shares and various restricted stock awards/units to arrive at the fully diluted shares outstanding.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/38", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-38", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 24, "beatId": "f6e479b9-e78e-4466-b555-8014d6cf5351", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and appendices", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 39, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/39", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-39", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 24, "beatId": "f6e479b9-e78e-4466-b555-8014d6cf5351", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and appendices", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 40, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes a pie chart for ownership, a summary table of activity, and detailed tables for top holder position changes and cost basis analysis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/40", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-40", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 24, "beatId": "f6e479b9-e78e-4466-b555-8014d6cf5351", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and appendices", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 41, "slideType": "appendix_data", "function": "analyze_data", "notes": "Data based on 13-F filings as of September 30, 2020.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/41", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-41", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 24, "beatId": "f6e479b9-e78e-4466-b555-8014d6cf5351", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and appendices", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 42, "slideType": "appendix_disclosure", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/42", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-42", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 24, "beatId": "f6e479b9-e78e-4466-b555-8014d6cf5351", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and appendices", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 43, "slideType": "appendix_disclosure", "function": "other", "notes": "Standard investment banking conflict of interest and relationship disclosure.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/43", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-43", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 24, "beatId": "f6e479b9-e78e-4466-b555-8014d6cf5351", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and appendices", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "docSlug": "jarvis-1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "documentTitle": "1 IBD presentation 2021 Fbl Financial Group Inc Barclays Capital", "authorId": "1-ibd-presentation-2021-fbl-financial-group-inc-barclays-capital", "authorName": null, "documentKindSlug": "deck", "documentKindLabel": "Deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-01-01 00:00:00", "orientation": null, "aspectRatio": null, "pageNumber": 44, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63/44", "deckHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63", "deckAnchorHref": "/decks/019f6b8e-d7d1-730b-b8f1-27a44a8f1b63#slide-44", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 24, "beatId": "f6e479b9-e78e-4466-b555-8014d6cf5351", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and appendices", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }